Blindness Completed Phase 3 Trials for Acetylsalicylic acid (DB00945)

Also known as: Blind / Blindness NOS

IndicationStatusPhase
DBCOND0009476 (Blindness)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00000151Early Treatment Diabetic Retinopathy Study (ETDRS)Treatment